Testimony on Behalf of BIO to the House Energy and Commerce Subcommittee on Health

Rachel King, CEO of GlycoMimetics, Inc., testified on behalf of BIO in the hearing entitled, "Treatments for an Ailing Economy: Protecting Health Care Coverage and Investing in Biomedical Research."